HFM
AZN icon

Hartford Funds Management’s AstraZeneca AZN Stock Holding History

Hartford Funds Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Sell
5,435
-402
-7% -$75.6K 0.08% 75
2026
Q1 		$1.13M Sell
5,837
-177
-3% -$34.1K 0.1% 59
2025
Q4 		$1.11M Sell
6,014
-103
-2% -$18.1K 0.09% 60
2025
Q3 		$939K Sell
6,117
-983
-14% -$149K 0.08% 47
2025
Q2 		$992K Buy
7,100
+658
+10% +$92.2K 0.09% 48
2025
Q1 		$947K Buy
6,442
+823
+15% +$119K 0.09% 49
2024
Q4 		$736K Buy
5,619
+299
+6% +$41.9K 0.07% 60
2024
Q3 		$829K Buy
5,320
+125
+2% +$20.2K 0.08% 52
2024
Q2 		$810K Buy
5,195
+475
+10% +$71.5K 0.08% 49
2024
Q1 		$640K Buy
4,720
+708
+18% +$93.8K 0.06% 54
2023
Q4 		$540K Buy
4,012
+1,117
+39% +$145K 0.05% 53
2023
Q3 		$392K Buy
2,895
+164
+6% +$22.4K 0.04% 48
2023
Q2 		$391K Buy
2,731
+336
+14% +$49.4K 0.04% 46
2023
Q1 		$332K Buy
2,395
+478
+25% +$64.3K 0.03% 52
2022
Q4 		$260K Buy
+1,917
New +$240K 0.03% 51

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Hartford Funds Management's AZN Position: Q2 2026 in Review

Hartford Funds Management reduced its AstraZeneca (AZN) stake by 6.9% in Q2 2026, selling an estimated $75.6K and leaving 5,435 shares worth $1.02M. The position accounts for 0.08% of the portfolio, ranked #75.

Hartford Funds Management first reported a position in AZN in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.13M in Q1 2026. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Hartford Funds Management held 5,435 shares of AstraZeneca worth $1.02M as of Q2 2026.
  • Hartford Funds Management sold 402 AstraZeneca shares in Q2 2026, an estimated $75.6K.
  • AstraZeneca made up 0.08% of Hartford Funds Management's portfolio in Q2 2026, its #75 holding.
  • Hartford Funds Management first reported a position in AstraZeneca in Q4 2022 and has held it in 15 quarters since.
  • Hartford Funds Management's AstraZeneca position peaked at $1.13M in Q1 2026.
  • 1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Hartford Funds Management's 13F filing for Q2 2026, filed 6 Aug 2026.